A Randomized, Controlled Trial to Evaluate the Safety and Effectiveness of the Route 92 Medical Reperfusion System (SUMMIT MAX)

NACompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

December 21, 2021

Primary Completion Date

February 19, 2024

Study Completion Date

May 22, 2024

Conditions
Acute Ischemic Stroke
Interventions
DEVICE

Route 92 Medical Reperfusion System

Mechanical thrombectomy for acute ischemic stroke patients with large vessel occlusions will be performed with direct aspiration consisting of navigating a large-bore catheter up to the face of the clot and initiating vacuum suction.

Trial Locations (30)

1023

Auckland City Hospital, Auckland

11794

Stony Brook University Hospital, Stony Brook

15213

UPMC, Pittsburgh

17822

Geisinger Clinic, Danville

19107

Thomas Jefferson University, Philadelphia

19718

Christiana Care, Newark

26506

West Virginia University, Morgantown

32207

Baptist Jacksonville, Jacksonville

33176

Baptist Hospital of Miami, Miami

37902

Fort Sanders Medical Center, Knoxville

40503

Baptist Health Lexington, Lexington

43214

Ohio Health, Columbus

43608

Mercy Health St. Vincent, Toledo

44195

Cleveland Clinic, Cleveland

45409

Wright State University, Dayton

60657

Advocate Aurora Health, Chicago

64111

Saint Luke's, Kansas City

66160

University of Kansas, Kansas City

75075

Medical City Plano, Plano

75390

University of Texas Southwestern, Dallas

78550

Valley Baptist, Harlingen

84123

University of Utah, Salt Lake City

85202

Banner Health, Mesa

95608

Mercy San Juan Medical Center, Carmichael

97219

OHSU, Portland

02111

Tufts, Boston

02118

Boston Medical Center, Boston

01655

University of Massachusetts, Worcester

08103

Cooper Health System, Camden

08854

Rutgers, Piscataway

All Listed Sponsors
lead

Route 92 Medical, Inc.

INDUSTRY

NCT05018650 - A Randomized, Controlled Trial to Evaluate the Safety and Effectiveness of the Route 92 Medical Reperfusion System (SUMMIT MAX) | Biotech Hunter | Biotech Hunter